Fred H Faas Selected Research

Gemfibrozil (Lopid)

4/2008	Hypertriglyceridemia and hypercholesterolemia: effects of drug treatment on fatty acid composition of plasma lipids and membranes.
5/2003	Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
12/2002	Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).
8/2002	Gemfibrozil lowers plasma lipids and increases polyunsaturated fatty acid content and oxidative susceptibility of lipoproteins in hypertriglyceridemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fred H Faas Research Topics

Disease

3	Coronary Disease (Coronary Heart Disease) 12/2010 - 12/2002
3	Hypertriglyceridemia 04/2008 - 02/2002
2	Insulin Resistance 05/2003 - 12/2002
1	Chronic Urticaria 05/2014
1	Nodular Goiter 05/2014
1	Hypercholesterolemia 04/2008
1	Graves Disease (Basedow Disease) 03/2007
1	Hyperthyroidism 03/2007
1	Sarcoidosis (Schaumann Disease) 03/2007
1	Disease Progression 03/2007
1	Prostatic Neoplasms (Prostate Cancer) 10/2006
1	Neoplasm Metastasis (Metastasis) 10/2006
1	Pathologic Constriction (Stenosis) 01/2006
1	Hyperplasia 01/2006
1	Myocardial Infarction 05/2003
1	Stroke (Strokes) 05/2003
1	Hyperinsulinism (Hyperinsulinemia) 12/2002
1	Diabetes Mellitus 12/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2002

Drug/Important Bio-Agent (IBA)

4	Gemfibrozil (Lopid)FDA LinkGeneric 04/2008 - 08/2002
3	LipidsIBA 04/2008 - 02/2002
2	LDL CholesterolIBA 12/2010 - 12/2002
2	Pharmaceutical PreparationsIBA 04/2008 - 08/2002
2	Triglycerides (Triacylglycerol)IBA 04/2008 - 05/2003
2	HDL CholesterolIBA 05/2003 - 12/2002
2	HDL LipoproteinsIBA 05/2003 - 12/2002
2	Lipoproteins (Lipoprotein)IBA 08/2002 - 02/2002
1	AntibodiesIBA 05/2014
1	oxidized low density lipoproteinIBA 12/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2008
1	Simvastatin (Zocor)FDA LinkGeneric 04/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2008
1	Atorvastatin (Lipitor)FDA Link 04/2008
1	Cholesterol Esters (Cholesteryl Esters)IBA 04/2008
1	Propylthiouracil FDA Link 03/2007
1	Antithyroid Agents (Antithyroid Drugs)IBA 03/2007
1	Hormones (Hormone)IBA 10/2006
1	CytokinesIBA 01/2006
1	Phenobarbital (Luminal)FDA Link 01/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	Adenosine Diphosphate (ADP)IBA 01/2006
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2006
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006
1	Clopidogrel (Plavix)FDA Link 01/2006
1	Fibric Acids (Fibrates)IBA 05/2003
1	Insulin (Novolin)FDA Link 12/2002
1	Glucose (Dextrose)FDA LinkGeneric 12/2002
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2002
1	Oleic Acid (Oleate)IBA 02/2002
1	Linoleic Acid (Linoleate)IBA 02/2002

Therapy/Procedure

2	Therapeutics 03/2007 - 05/2003
1	Metastasectomy 10/2006
1	Carotid Endarterectomy 01/2006